Table 1 Main characteristics of studies exploring the relationship between SIRT6 expression and tumor prognosis
Authors | Year | Region | Cancer type | Stage/ Grade | No. of Patients | Follow-up Time Median (range) | Detection Method | Outcomes | Location | NOS Score |
|---|---|---|---|---|---|---|---|---|---|---|
Zhang [14] | 2020 | Korea | OS | I–IV | 37 | NR | IHC (CST) | OS, DFS | NR | 8 |
Han [15] | 2019 | China | HCC | NR | 120 | 60Â M | IHC (Bioss) | OS, DFS | NR | 7 |
Bae [16] | 2018 | Korea | OC | I–IV | 104 | 82 M(1–209) | IHC (CST) | OS, DFS | Nu | 8 |
Tian [10] | 2018 | China | CRC | I–IV | 90 | NR | IHC (CST) | OS | Nu | 7 |
Li [17] | 2018 | China | CRC | I–IV | 97 | NR | IHC (Abcam) | OS | Nu | 7 |
Zhu [18] | 2018 | China | NSCLC | I–IV | 86 | 51 M | IHC (Abcam) | OS, DFS | Nu | 6 |
Chen [4] | 2017 | China | NSCLC | I–III | 122 | 44 M(1–60) | IHC (Abcam) | OS | Cy | 7 |
Zhou [19] | 2017 | China | GC | I–IV | 68 | NR | IHC (CST) | OS, DFS | NR | 6 |
Bai [11] | 2016 | China | NSCLC | I–IV | 174 | 30 M(0–120) | IHC (Abcam) | OS | NR | 5 |
Bae [20] | 2016 | Korea | BRC | I–IV | 142 | 148.8 M(7.7–198.6) | IHC (Lifespan) | OS, DFS | Nu | 7 |
Kugel [9] | 2016 | USA | PDAC | NR | 120 | 33Â M | IHC (NR) | OS | NR | 9 |
Ran [21] | 2016 | China | HCC | I–III | 53 | NR | IHC (Novus) | OS | NR | 8 |
Azuma [22] | 2015 | Japan | NSCLC | I–IV | 98 | NR | IHC (Abnova) | OS | Cy | 7 |
Thirumurthi [23] | 2014 | China | BRC | NR | 126 | NR | IHC (CST) | OS | NR | 8 |
Khongkow [24] | 2013 | China | BRC | I–III | 118 | NR | IHC (CST) | OS | Nu | 8 |